History & Overview
Annual Report
President's Pages
Center News
Community Affairs
Code of Conduct
Make a Gift
Cycle for Survival
Fred's Team
Yankees Universe Fund
Thomas Blake Sr. Memorial Research Fund
Donating Blood & Platelets
Volunteering
Thrift Shop
Park Avenue Potluck CELEBRATIONS
Press Releases
In the News
Information for Journalists
News@MSKCC
Manhattan
New Jersey
Long Island
Westchester
Working at Memorial Sloan-Kettering
Work Sites
College Recruitment
About Nursing
Job Fairs & Career Days
IS Careers
Job Search & Apply Online
Clinical Research Program
Brain Tumor & Central Nervous System
Breast Cancer
Colorectal Cancer
Genitourinary Cancer
Geriatrics
Gynecologic Cancer
Head and Neck Cancer
Hematology
Hepatobiliary
Infectious Disease
Integrative Medicine
Leukemia
Clinical Trials
Disease Management Team
Lymphoma
Melanoma
Pain and Palliative Care
Pediatric Cancers
Primary Bone
Psychiatry and Behavioral Sciences
Radiation Sciences
Soft Tissue Sarcoma
Thoracic
Transplantation
Upper Gastrointestinal
Home
>
Research
>
Memorial Hospital Research
>
Clinical Research Program
>
Leukemia
Clinical Trials
Clicking a link below will scroll the
page down to the relevant section
Acute Lymphoblastic Leukemia
Acute Myelocytic Leukemia
Acute Myelogenous Leukemia
Chronic Lymphocytic Leukemia
Chronic Myelocytic Leukemia
Acute Lymphoblastic Leukemia
top
A Clinical Trial for Patients with Standard Risk B-Precursor Acute Lymphoblastic Leukemia
Shukla, Neerav, MD
[Protocol 06-039]
A Phase I Study of Clofarabine Plus Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients with Relapsed or Refractory Acute Leukemia
Steinherz, Peter, MD
[Protocol 07-012]
A Phase I Study of Induction Therapy with Cytarabine, High-Dose Mitoxantrone, and Dasatinib for Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia
Lamanna, Nicole, MD
[Protocol 09-046]
A Phase I Trial of B-Cell Acute Lymphoblastic Leukemia Treated with Autologous T Cells Gene-Targeted to the B-Cell Antigen CD19
Brentjens, Renier, MD, PhD
[Protocol 09-114]
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adults with Hematological Cancers
Barker, Juliet, MBBS
[Protocol 07-072]
A Phase II Pilot Trial of Hematopoietic Stem Cell Transplantation with Total Body Irradiation, Cyclophosphamide & Fludarabine to Treat Patients with Fanconi Anemia Lacking a Genotypically Identical Donor
Boulad, Farid, MD
[Protocol 01-062]
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia
Barker, Juliet, MBBS
[Protocol 08-087]
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Leukemia Following Total Body Irradiation and Stem Cell Transplant
Oeffinger, Kevin, MD
[Protocol 07-092]
Classification of Acute Lymphoblastic Leukemia
Shukla, Neerav, MD
[Protocol 06-023]
Acute Myelocytic Leukemia
top
A Phase I Study of Clofarabine Plus Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients with Relapsed or Refractory Acute Leukemia
Steinherz, Peter, MD
[Protocol 07-012]
A Phase I Study of STA9090 in Patients with Hematologic Malignancies
Heaney, Mark, MD, PhD
[Protocol 09-095]
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adults with Hematological Cancers
Barker, Juliet, MBBS
[Protocol 07-072]
A Phase III Study of Gemtuzumab Ozogamicin Plus Conventional Chemotherapy in Children, Adolescents, and Young Adults with Acute Myeloid Leukemia
Shukla, Neerav, MD
[Protocol 09-091]
Acute Myelogenous Leukemia
top
A Phase I Study of R7112 in Patients with Leukemia or Lymphoma
Maslak, Peter, MD
[Protocol 09-075]
A Phase I Study of STA9090 in Patients with Hematologic Malignancies
Heaney, Mark, MD, PhD
[Protocol 09-095]
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adults with Hematological Cancers
Barker, Juliet, MBBS
[Protocol 07-072]
A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS
Castro-Malaspina, Hugo, MD
[Protocol 08-008]
A Phase III Study of Gemtuzumab Ozogamicin Plus Conventional Chemotherapy in Children, Adolescents, and Young Adults with Acute Myeloid Leukemia
Shukla, Neerav, MD
[Protocol 09-091]
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia
Barker, Juliet, MBBS
[Protocol 08-087]
AAML0431 for the Treatment of Young Down Syndrome Children with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Shukla, Neerav, MD
[Protocol 09-080]
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Leukemia Following Total Body Irradiation and Stem Cell Transplant
Oeffinger, Kevin, MD
[Protocol 07-092]
Chronic Lymphocytic Leukemia
top
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies
Barker, Juliet, MBBS
[Protocol 06-066]
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia
Brentjens, Renier, MD, PhD
[Protocol 06-138]
A Phase I Study of R7112 in Patients with Leukemia or Lymphoma
Maslak, Peter, MD
[Protocol 09-075]
A Phase I-II Study of Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Previously Treated Patients with Chronic Lymphocytic Leukemia and Other Low Grade B-Cell Cancers
Lamanna, Nicole, MD
[Protocol 05-077]
A Phase I/II Study of Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Patients with Relapsed/Refractory Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)
Gerecitano, John, MD, PhD
[Protocol 05-103]
A Phase II Study of Lenalidomide in Patients with Chronic Lymphocytic Leukemia Age 65 and Older
Lamanna, Nicole, MD
[Protocol 09-045]
A Phase II Study of Pentostatin with Cyclophosphamide and Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia
Lamanna, Nicole, MD
[Protocol 05-051]
Chronic Myelocytic Leukemia
top
A Phase I Study of R7112 in Patients with Leukemia or Lymphoma
Maslak, Peter, MD
[Protocol 09-075]
A Phase I Study of STA9090 in Patients with Hematologic Malignancies
Heaney, Mark, MD, PhD
[Protocol 09-095]
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Leukemia Following Total Body Irradiation and Stem Cell Transplant
Oeffinger, Kevin, MD
[Protocol 07-092]
Site Map
|
Index
Legal Disclaimer
|
Privacy Practices
|
Public Notices
©2010 Memorial Sloan-Kettering Cancer Center. 212-639-2000
1275 York Avenue New York, NY 10065.
PublicAffairs@mskcc.org